A Randomized, Double-Blind, Active- and Placebo-Controlled, Crossover Study Assessing the Effect of 600 mg Gabapentin Enacarbil on Simulated Driving in Healthy Subjects.

Trial Profile

A Randomized, Double-Blind, Active- and Placebo-Controlled, Crossover Study Assessing the Effect of 600 mg Gabapentin Enacarbil on Simulated Driving in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Jul 2013

At a glance

  • Drugs Gabapentin enacarbil (Primary) ; Diphenhydramine
  • Indications Restless legs syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 04 Nov 2011 Actual initiation date changed from Jul 2011 to Jun 2011 as reported by ClinicalTrials.gov.
    • 04 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
    • 04 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top